|
|
 |
 |
 |
| Clinical testing is a vital part of disease diagnosis
and treatment decisions, as
well as health checkups. Our company mission is to contribute to
quality healthcare
for all by efficiently supplying medical institutions with accurate
test data.
Since our company was established in 1962, we have broadened the
scope of our
business in line with advances in medical and testing technologies.
At present, the
FALCO Group is involved in genetic testing, clinical research and
trials, research
and development in clinical biochemistry, medical information technology,
food
sanitation and environmental health testing, and dispensing pharmacies,
as well as
our core business of clinical testing.
Through its businesses the FALCO Group will continue to support health
in body
and spirit, for a rewarding future for all. |
 |
|
 |
| Aug.6,2010 |
Consolidated Financial Report for the Three Months Ended June 30,2010 |
| Jul.20,2010 |
FALCO to Transfer Management Business to its Subsidiary by (Simple Absorption-type) Corporate Split |
| Jul.20,2010 |
Announcement Regarding Establishment of a Subsidiary |
| Jun.30,2010 |
Regarding Development of System Tool That Enables Test Acceptance through Other Makers’eChart |
| Jun.22,2010 |
Notice of Personnel Changes |
| Jun.14,2010 |
Announcement on the Release of the Newest OS Windows 7 Supported New Version of the eChart “@homeDr. (At home doctor)” Designed for Clinics |
| May.17,2010 |
Announcement of the Formulation of the Medium-Term Management Plan “plan2013” |
| May.7,2010 |
Consolidated Earnings Report For Fiscal Year Ended March 31, 2010 |
| May.6,2010 |
Announcement of a Revision in the Earnings Forecast (Consolidated) for the Full Term for the Period Ended March 2010 |
| Apr.30,2010 |
Announcement of a Revision in the Earnings Forecast (Consolidated and Non-Consolidated) for the Full Term for the Period Ended March 2010 |
| Apr.6,2010 |
Notice of Conclusion of Exclusive Distribution Agreement with Saladax Biomedical for the 5-FU MYCARE Assay in Japan |
| Mar.15,2010 |
Announcement Concerning Organizational System and Personnel |
| Feb.15,2010 |
Announcement Concerning Organizational Structure of FALCO SD HOLDINGS Co., Ltd. and Changes of Representative Director and Group Officers |
| Jan.27,2010 |
Consolidated Earnings Report for the Three Months Ended December 20, 2009 (September 21, 2009-December 20, 2009) |
| Jan.25,2010 |
Announcement Regarding Appraisal Loss on Investment Securities for the First Quarter of the Period Ending March 2010 |
| Dec.17,2009 |
Announcement Concerning the Passage of Approval at the Ordinary General Meeting of Shareholders for Agreements on an Absorption-Type Split and a Share Swap |
| Nov.17,2009 |
Announcement Concerning the Conclusion of a Commitment Line Agreement |
| Nov.5,2009 |
Consolidated Earnings Report For Fiscal Year Ended September 20, 2009 |
| Nov.5,2009 |
Announcement Concerning Changes of Directors and Other Personnel |
| Nov.5,2009 |
Announcement Concerning a Change of Business Name and Accounting Term and Partial Changes to the Company’s Articl of Incorporation |
| Nov.5,2009 |
Announcement Concerning Entry into a Share Swap Agreement between FALCO biosystems Ltd. and SIMENO DRUG Co., Ltd. and Entry into an Agreement with FALCO Communications Ltd. on an Absorption-Type Split |
| Sep.28,2009 |
Announcement Concerning the Signing of the Basic Agreement for FALCO biosystems Ltd. to Implement Share Swap and Business Merger with SIMENO DRUG Co., Ltd. and the Conversion of FALCO biosystems Ltd. into a Pure Holding Company |
| Sep.4,2009 |
Changes in the Schedule, etc. of the Share Swap and Business Merger with SIMENO DRUG Co., Ltd. and Related Matters of Agreement |
| Jul.28, 2009 |
Consolidated Earnings Report for the Nine Months Ended June 20, 2009 |
| Jul.23, 2009 |
Announcement of a Revision in the Earnings Forecast (Consolidated and Non-Consolidated) for the Full Term for the Period Ending September 2009 |
| Apr.28,2009 |
Consolidated Earnings Report for Six Months Ended March 20, 2009 |
| Apr.23,2009 |
Announcement of a Revision in the Earnings Forecast (Consolidated and Non-Consolidated) for the Six Months Ending March 20 and the Full Term for the Period Ending September 2009 |
| Apr.23,2009 |
Announcement Regarding Appraisal Loss on Investment Securities for the 2nd Quarter of the Period Ending September 2009 |
| Apr.10,2009 |
Notice of Acquisition of Treasury Stock and Its Completion |
| Mar.10,2009 |
Notice of Acquisition of Treasury Stock |
| Feb.16,2009 |
Notice of Decision Regarding Acquire Treasury Stock |
| Feb.4,2009 |
Results of Treasury Stock Acquisition on J-Net Market of the Osaka Securities Exchange |
| Feb.3,2009 |
Notice of Decision to Acquire Treasury Stock and Make "Treasury Stoc Acquisition on J-Net Market of the Osaka Securities Exchange" |
| Jan.30,2009 |
FALCO biosystems Ltd. to Implement Share Swap and Business Merger with SIMENO DRUG Co., Ltd; FALCO biosystems to Change into Pure Holding Company |
| Jan.28,2009 |
Consolidated Earnings Report for the Three Months Ended December 20, 2008 |
| Jan.19,2009 |
Notice of a Merger between Consolidated Subsidiaries |
| Jan.19,2009 |
Notice of Personnel Changes |
| Jan.9,2009 |
Notice
of Acquisition of Treasury Stock and Its Completion |
| Jan.9,2009 |
Announcement
of the Posting of an Appraisal Loss on Investment Securities |
| Dec.8,2008 |
Notice
of Acquisition of Treasury Stock |
| Nov.5,2008 |
Consolidated
Earnings Report For Fiscal Year Ended September 20, 2008 |
| Nov.5,2008 |
Announcement
of the Retirement of an Auditor |
| Nov.5,2008 |
Notice
of Decision Regarding Acquire Treasury Stock |
| Nov.4,2008 |
Announcement
of a Revision of the Earnings Forecast
(Consolidated and Non-Consolidated) |
| Oct.29,2008 |
Announcement
of the Posting of an Appraisal Loss on Investment Securities |
| Oct.15,2008 |
Release
of research study result |
| Oct.1,2008 |
Notice
of Conclusion of CYP2D6*4 Gene Patent Licensing Agreement with LGC |
| Sep.16,2008 |
Notice of Organizational and Personnel Changes |
| Sep.16,2008 |
Notice of a Merger between Consolidated Subsidiaries |
| Aug.11,2008 |
@homeDr.
("at-home doctor"), an electronic medical chart for use at clinics,
released |
| Aug.5,2008 |
Notice of Acquisition of Treasury Stock and Its Completion |
| Jul.25,2008 |
Consolidated Earnings Report For the Nine Months Ended June 20,
2008 |
| Jul.10,2008 |
Notice
of Acquisition of Treasury Stock |
| Jun.10,2008 |
Notice
of Acquisition of Treasury Stock |
| May.21,2008 |
Notice
of Decision Regarding Acquire Treasury Stock |
| May.21,2008 |
Notice
of Acquisition of Treasury Stock |
| May.8,2008 |
Consolidated
Interim Earnings Report For Fiscal Year Ending September 20, 2008 |
| May.8,2008 |
Notice
of Acquisition of Treasury Stock |
| May.1,2008 |
Notice
of Revisions to Forecasts for Interim and Full Fiscal Year
(Consolidated and
Non-Consolidated Basis) |
| Apr.10,2008 |
Notice
of Acquisition of Treasury Stock |
| Mar.31.2008 |
Commencement
of ASP-based content services for ”Ethical Drug Information Retrieval”and ”Consultation
Appointmen” |
| Mar.31.2008 |
Commencement
of commissioned ”Gene-expression test for predicting postoperative recurrence
of lung adenocarcinoma” based on the consignment contract with Oncomics,
Co., Ltd. |
|
|
|